SynthesisCancer immunology, immunotherapy : CII2023

Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patients.

Cheng-Long Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.